Title |
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
|
---|---|
Published in |
Investigational New Drugs, November 2013
|
DOI | 10.1007/s10637-013-0045-6 |
Pubmed ID | |
Authors |
Jonathan E. Rosenberg, Richard M. Bambury, Eliezer M. Van Allen, Harry A. Drabkin, Primo N. Lara, Andrea L. Harzstark, Nikhil Wagle, Robert A. Figlin, Gregory W. Smith, Levi A. Garraway, Toni Choueiri, Fredrik Erlandsson, Damian A. Laber |
Mendeley readers
The data shown below were compiled from readership statistics for 216 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
China | 1 | <1% |
Unknown | 215 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 61 | 28% |
Researcher | 40 | 19% |
Student > Master | 19 | 9% |
Student > Bachelor | 18 | 8% |
Student > Postgraduate | 11 | 5% |
Other | 29 | 13% |
Unknown | 38 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 62 | 29% |
Agricultural and Biological Sciences | 30 | 14% |
Medicine and Dentistry | 23 | 11% |
Chemistry | 16 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 6% |
Other | 23 | 11% |
Unknown | 48 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#1,697,293
of 22,854,458 outputs
Outputs from Investigational New Drugs
#30
of 1,168 outputs
Outputs of similar age
#14,886
of 187,982 outputs
Outputs of similar age from Investigational New Drugs
#1
of 14 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,168 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,982 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.